WELL Health Technologies (TSE:WELL - Free Report) had its price target lifted by TD Securities from C$8.00 to C$8.50 in a report released on Tuesday,BayStreet.CA reports.
Several other analysts also recently weighed in on WELL. Ventum Financial dropped their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating on the stock in a research note on Tuesday, October 29th. Haywood Securities increased their price target on WELL Health Technologies from C$8.00 to C$10.00 in a research report on Friday. Scotiabank boosted their price objective on WELL Health Technologies from C$6.00 to C$7.00 in a report on Monday. Finally, CIBC lifted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday.
Read Our Latest Analysis on WELL
WELL Health Technologies Stock Performance
WELL stock traded up C$0.10 during trading on Tuesday, reaching C$7.09. The company had a trading volume of 2,137,436 shares, compared to its average volume of 893,325. The company has a debt-to-equity ratio of 41.57, a quick ratio of 1.02 and a current ratio of 1.25. WELL Health Technologies has a twelve month low of C$3.41 and a twelve month high of C$7.17. The company has a market cap of C$1.77 billion, a price-to-earnings ratio of 12.44, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The firm has a 50-day simple moving average of C$5.24 and a 200-day simple moving average of C$4.73.
About WELL Health Technologies
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Read More
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
